Palisade Bio (PALI) FCF Margin Growth (5y) (2016 - 2023)
Palisade Bio (PALI) FCF Margin Growth (5y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 7.26 Mn |
| Dec 31, 2020 | 9.59 Mn |
| Sep 30, 2020 | 19.08 Mn |
| Jun 30, 2020 | 16.45 Mn |
| Mar 31, 2020 | 13.45 Mn |
| Dec 31, 2019 | -660,207.00 |
| Sep 30, 2019 | -1.33 Mn |
| Jun 30, 2019 | 3.06 Mn |
| Mar 31, 2019 | -76,863.00 |
| Dec 31, 2018 | 2.83 Mn |
| Sep 30, 2018 | 2.79 Mn |
| Jun 30, 2018 | 13.33 Mn |
| Mar 31, 2018 | -7.16 Mn |
| Dec 31, 2017 | 10.02 Mn |
| Sep 30, 2017 | -13.26 Mn |
| Jun 30, 2017 | -13.17 Mn |
| Mar 31, 2017 | -17.61 Mn |
| Dec 31, 2016 | -4.61 Mn |
| Sep 30, 2016 | -18.17 Mn |